Skip to main content
logo
Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
36.35
-0.04 (-0.10%)
Dec 8, 2025, 1:17 PM EST - Market open

Ultragenyx Pharmaceutical Revenue by Segment

Period EndingJun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
Product
321.49M314.47M285.47M265.30M230.30M198.70M180.40M157.60M
Product Growth
39.59%58.26%58.24%68.34%55.82%45.67%51.72%43.01%
Other
288.69M276.21M274.71M257.40M250.90M243.80M253.80M252.60M
Other Growth
15.06%13.29%8.24%1.90%2.37%2.65%8.28%13.27%

Revenue by Geography

Period EndingJun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
North America
354.58M340.56M340.46M316.40M307.30M297.70M307.10M299.00M
North America Growth
15.39%14.40%10.86%5.82%3.05%4.02%9.29%11.94%
Latin America
144.47M150.40M130.71M130.30M109.50M89.70M77.30M67.40M
Latin America Growth
31.93%67.67%69.10%93.32%70.30%55.46%72.93%61.24%
Europe
97.65M87.45M80.12M69.60M60.40M54.20M47.60M42.70M
Europe Growth
61.68%61.35%68.33%63.00%58.53%44.15%30.77%28.61%
Japan
12.89M9.69M-7.60M6.50M---------------
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.